Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Harpreet Takhar"'
Autor:
Deborah E. Malden, John M. McLaughlin, Vennis Hong, Joseph Lewnard, Bradley K. Ackerson, Laura Puzniak, Jeniffer S. Kim, Harpreet Takhar, Timothy B. Frankland, Jeff M. Slezak, Sara Y. Tartof
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract A clear understanding of real-world uptake of nirmatrelvir–ritonavir for treatment of SARS-CoV-2 can inform treatment allocation strategies and improve interpretation of effectiveness studies. We used data from a large US healthcare system
Externí odkaz:
https://doaj.org/article/d3fe580778384714bf7e778dfa12f3e1
Autor:
Ana Florea, Lina Sy, Lei Qian, Bradley Ackerson, Yi Luo, Jun Wu, Yanjun Cheng, Jennifer Ku, Leticia Vega Daily, Harpreet Takhar, Jeannie Song, Elizabeth Chmielewski-Yee, O’Mareen Spence, Harry Seifert, Driss Oraichi, Hung Fu Tseng
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTWe evaluated the vaccine effectiveness (VE) of two doses of recombinant zoster vaccine (RZV) against herpes zoster (HZ) and postherpetic neuralgia (PHN) in Chinese adults at Kaiser Permanente Southern California (KPSC). Chinese KPSC members w
Externí odkaz:
https://doaj.org/article/d183bd06668d4f9b85c20fcf2d7ac175
Autor:
Joseph A. Lewnard, Vennis Hong, Jeniffer S. Kim, Sally F. Shaw, Bruno Lewin, Harpreet Takhar, Marc Lipsitch, Sara Y. Tartof
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-10 (2023)
Abstract Host immune responses are a key source of selective pressure driving pathogen evolution. Emergence of many SARS-CoV-2 lineages has been associated with enhancements in their ability to evade population immunity resulting from both vaccinatio
Externí odkaz:
https://doaj.org/article/3aa70fc922254106a39203913c8fdfe3
Autor:
Joseph A. Lewnard, Vennis Hong, Jeniffer S. Kim, Sally F. Shaw, Bruno Lewin, Harpreet Takhar, Sara Y. Tartof
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-11 (2023)
Continuous monitoring of SARS-CoV-2 variant properties is important for public health planning. Here, the authors use data from the United States and show that Omicron BA.4/5 subvariants, which became dominant in mid-2022, have stronger immune escape
Externí odkaz:
https://doaj.org/article/ee50eed2d5a94458aa9aa192002f5ff3
Autor:
Hung Fu Tseng, Margaret Chi, Peggy Hung, Rafael Harpaz, D. Scott Schmid, Philip LaRussa, Lina S. Sy, Yi Luo, Kimberly Holmquist, Harpreet Takhar, Steven J. Jacobsen
Publikováno v:
International Journal of Infectious Diseases, Vol 66, Iss C, Pp 99-106 (2018)
Background: Studies have investigated a possible association between family history of HZ and the occurrence of HZ. However, the results were inconclusive and susceptible to bias. We evaluated this association in an elderly population. Methods: The m
Externí odkaz:
https://doaj.org/article/cb27fc5e48314ad1b9742bbf460b407a
Autor:
Joseph A Lewnard, John M McLaughlin, Debbie Malden, Vennis Hong, Laura Puzniak, Bradley K Ackerson, Bruno J Lewin, Jeniffer S Kim, Sally F Shaw, Harpreet Takhar, Luis Jodar, Sara Y Tartof
Publikováno v:
The Lancet. Infectious diseases, vol 23, iss 7
BackgroundIn the USA, oral nirmatrelvir-ritonavir is authorised for use in patients aged 12 years or older with mild-to-moderate COVID-19 who are at risk of progression to severe disease and hospitalisation. We aimed to establish the effectiveness of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c44cf3e9facb6c38b86da6b65a9c186
https://escholarship.org/uc/item/1cp1x02k
https://escholarship.org/uc/item/1cp1x02k
Autor:
Sara Y Tartof, Timothy B Frankland, Laura Puzniak, Jeff M Slezak, Vennis Hong, Harpreet Takhar, Oluwaseye A Ogun, Sarah Simmons, Fagen Xie, Joann Zamparo, Bradley K Ackerson, Luis Jodar, John M McLaughlin
Publikováno v:
Journal of the Pediatric Infectious Diseases Society. 12:177-179
In a 1:1 matched test-negative design among 5- to 11-year-olds in the Kaiser Permanente Southern California health system (n = 3984), BNT162b2 effectiveness against the omicron-related emergency department or urgent care encounters was 60% [95%CI: 47
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1338003ed2ae3afef21613d848d93185
https://doi.org/10.1093/jpids/piad005
https://doi.org/10.1093/jpids/piad005
Autor:
Sara Y Tartof, Jeff M Slezak, Laura Puzniak, Vennis Hong, Timothy B Frankland, Bradley K Ackerson, Harpreet Takhar, Oluwaseye A Ogun, Sarah Simmons, Joann M Zamparo, Luis Jodar, John M McLaughlin
Publikováno v:
The Lancet Infectious Diseases. 22:1663-1665
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceb56923edec80703fe72171e7cb38a6
https://doi.org/10.1016/s1473-3099(22)00692-2
https://doi.org/10.1016/s1473-3099(22)00692-2
Autor:
Joseph A. Lewnard, John M. McLaughlin, Debbie Malden, Vennis Hong, Laura Puzniak, Bradley K. Ackerson, Bruno J. Lewin, Jeniffer S. Kim, Sally F. Shaw, Harpreet Takhar, Luis Jodar, Sara Y. Tartof
Publikováno v:
medRxiv
BackgroundIn the United States, oral nirmatrelvir-ritonavir (Paxlovid™) is authorized for use among patients aged ≥12 years with mild-to-moderate SARS-CoV-2 infection who are at risk for progression to severe COVID-19, including hospitalization.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f87211005b63a568904df4ba80392dab
https://doi.org/10.1101/2022.10.02.22280623
https://doi.org/10.1101/2022.10.02.22280623
Autor:
Darios Getahun, Yinka Oyelese, Morgan Peltier, Meiyu Yeh, Vicki Y. Chiu, Harpreet Takhar, Nehaa Khadka, Nana Mensah, Chantal Avila, Michael J. Fassett
Publikováno v:
American Journal of Obstetrics and Gynecology. 228:S122-S123
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a0c5372938c43a54bd7f1a173d7b104
https://doi.org/10.1016/j.ajog.2022.11.248
https://doi.org/10.1016/j.ajog.2022.11.248